WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹5.13 Cr | ₹4.95 Cr | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹5.13 Cr |
| Mar2025 | ₹4.95 Cr |
| Mar2024 | ₹3.95 Cr |
| Mar2023 | ₹3.44 Cr |
| Mar2022 | ₹0.21 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.13 Cr | 3.63 | |
| Mar2025 | ₹4.95 Cr | 25.46 | |
| Mar2024 | ₹3.95 Cr | 14.84 | |
| Mar2023 | ₹3.44 Cr | 1,513.62 | |
| Mar2022 | ₹0.21 Cr | - | |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,261.9 Cr | -4.4% | 15.7% | 13.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -4.4% |
15.7% |
13.2% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses